Nemaura Medical Inc expected to post a loss of 16 cents a share - Earnings Preview

Nemaura Medical

23/06/2023 21:09

* Nemaura Medical Inc  NMRD.OQ   NMRD.O  is expected to show
a
fall in quarterly revenue when it reports  results on June 27
(estimated). 
    * The New York City-based  company is expected to report  a
37.5% decrease in revenue to $200 thousand from $320 thousand a
year ago, according to the mean estimate from 3 analysts, based
on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Nemaura Medical Inc
is
for a loss of 16 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Nemaura
Medical
Inc is $7​, above​ its last closing price of $0.68. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Dec. 31 2022  -0.18       -0.18      -0.07     Beat    61.1
 Sep. 30 2022  -0.17       -0.17      -0.17     Met     0
 Jun. 30 2022  -0.17       -0.17      -0.17     Met     0​
 Mar. 31 2022  -0.14       -0.14      -0.15     Missed  -9.8
 ​​Dec.        -0.14       -0.14      -0.15     Missed  -7.1
 31 2021                                                
 Sep. 30 2021  -0.11       -0.11      -0.15     Missed  -36.4​
 Jun. 30 2021  -0.08       -0.08      -0.14     Missed  -75
 Mar. 31 2021              -0.08      -0.09     Missed  -12.5
 This summary was machine generated June 23 at 20:09 GMT.  All
figures in US dollars  unless otherwise stated